In exchange, Hengrui will receive $500m in upfront fees and will be eligible for approximately $12bn in development, ...

AbbVie has shared promising top-line results from a late-stage study of its JAK inhibitor Rinvoq (upadacitinib) in severe ...

The Cannes Lions International Festival of Creativity is known for its topical breadth – and the smart pharma marketers who ...

Cuttsy+Cuttsy is excited to announce the addition of three talented professionals to the team: Flo, an enthusiastic Account ...

There’s a growing trend of LMS platforms leveraging AI to offer smart suggestions, automated assessments and adaptive ...

In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content ...